TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery

NCT03881878 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

67

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

DRUG: TAHP and AHP
DRUG: TAHP plus AC and AHP

Sponsor

Samsung Medical Center